SCHEMBL2907044

SCHEMBL2907044

CCOC(=O)C1CC1C(C(=O)NC1CCCCC1)C1(C(OC)c2ccccc2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 3/20 0.39
TSHR P16473 5/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP3A4 P08684 4/20 0.36
CYP2D6 P10635 3/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 2/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
CYP1A2 P05177 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MDM2 Q00987 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CCR1 P32246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910028 0.85 SMN1; SMN2 (0.45) TP53SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL2915018 0.80 SMN1; SMN2 (0.41) TP53SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL2912642 0.77 SMN1; SMN2 (0.43) SMN1; SMN2TSHRMEN1KMT2ACYP3A4
SCHEMBL2913502 0.77 YAP1 (0.44) TP53SMN1; SMN2MAPTTSHRMEN1
SCHEMBL2305802 0.76 TSHR (0.46) SMN1; SMN2MAPTTSHRMEN1KMT2A
SCHEMBL2914662 0.76 MAPT (0.44) TP53SMN1; SMN2MAPTTSHRMEN1
SCHEMBL2914472 0.75 MEN1 (0.36) SMN1; SMN2TSHRMEN1KMT2ACYP3A4
SCHEMBL2913162 0.74 KMT2A (0.42) SMN1; SMN2TSHRMEN1KMT2ACYP3A4
SCHEMBL2307838 0.73 NR1H4 (0.41) TP53SMN1; SMN2MAPTTSHRCYP3A4
SCHEMBL2914533 0.73 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed